BioWorld MedTech

June 14, 2010

Sicel touts dose device at radiotherapeutics meeting

Undergoing radiation therapy is often the best chance a patient has at getting rid of a tumor, but the treatment sometimes comes with an unfortunate – even fatal – price if the patient receives too much. (Medical Device Daily) Read More

AAPM; clinics responsible for QA, but industry must pitch in

Financings roundup: SonoSite to repurchase up to $50M of its common stock

Checkpoint's neurostimulation device launched nationwide

International report: SFDA clears China Medical Technologies' HPV-DNA chip

MDD's food for med-tech thought

Deals roundup: Orthopaedic Synergy wraps up Praxim acquisition

Agreements/contracts: TransEnterix selects Syspro ERP software for real-time data

Court Report: U.S. wins $2.75 million in Medicaid fraud settlement

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 17, 2026.

AI-generated illustration of a neuron with tau protein aggregation

AAIC 2026: Age of amyloid is being joined by time of tau

BioWorld

The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...

Celia trial: data strong, analysts skeptical

BioWorld

Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 14, 2026

Voyager’s gene therapy reduces tau levels in AD models

BioWorld Science

At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...